Dobutamine Cardiac Magnetic Resonance Results Predict Cardiac Prognosis in Women With Known or Suspected Ischemic Heart Disease

JACC: Cardiovascular Imaging

Volumn 2, Issue 3, 2009, Pages 299-307

  Wallace, Eric L ^a   Morgan, Timothy M ^a   Walsh, Thomas F ^a   Dall'Armellina, Erica ^a   Ntim, William ^a   Hamilton, Craig A ^a   Hundley, W Gregory ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

magnetic resonance; prognosis; women

Indexed keywords

ATROPINE; DOBUTAMINE;

ADULT; ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; EXERCISE TEST; FEMALE; HEART DEATH; HEART INFARCTION; HEART VENTRICLE WALL MOTION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; NON INVASIVE MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT;

AGED; ATROPINE; CARDIOTONIC AGENTS; DOBUTAMINE; HUMANS; KAPLAN-MEIERS ESTIMATE; MAGNETIC RESONANCE IMAGING, CINE; MIDDLE AGED; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; VENTRICULAR FUNCTION, LEFT; WOMEN'S HEALTH SERVICES;

EID: 61649096849     PISSN: 1936878X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcmg.2008.10.015     Document Type: Article

References (29)

1. Hundley W.G., Morgan T.M., Neagle C.M., Hamilton C.A., Rerkpattanapipat P., and Link K.M. Magnetic resonance imaging determination of cardiac prognosis. Circulation 106 (2002) 2328-2333
2. Jahnke C., Nagel E., Gebker R., et al. Prognostic value of cardiac magnetic resonance stress tests: adenosine stress perfusion and dobutamine stress wall motion imaging. Circulation 115 (2007) 1769-1776
3. Klem I., Greulich S., Heitner J.F., et al. Value of cardiovascular magnetic resonance stress perfusion testing for the detection of coronary artery disease in women. J Am Coll Cardiol Img 1 (2008) 436-445
4. Hundley W.G., Hamilton C.A., Thomas M.S., et al. Utility of fast cine magnetic resonance imaging and display for the detection of myocardial ischemia in patients not well suited for second harmonic stress echocardiography. Circulation 100 (1999) 1697-1702
5. Hamilton C.A., Link K.M., Salido T.B., Thomas M.S., Epstein F.H., and Hundley W.G. Is imaging at intermediate doses necessary during dobutamine stress magnetic resonance imaging?. J Cardiovasc Magn Reson 3 (2001) 297-302
6. Cerqueira M.D., Weissman N.J., Dilsizian V., et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 105 (2002) 539-542
7. Lawson M.A., Blackwell G.G., Davis N.D., Roney M., Dell'Italia L.J., and Pohost G.M. Accuracy of biplane long-axis left ventricular volume determined by cine magnetic resonance imaging in patients with regional and global dysfunction. Am J Cardiol 77 (1996) 1098-1104
8. Chen C.G., Li L., Chen L.L., et al. Incremental doses of dobutamine induce a biphasic response in dysfunctional left-ventricular regions subtending coronary stenoses. Circulation 92 (1995) 756-766
9. Thygesen K., Alpert J., and White H. Universal Definition of Myocardial Infarction. J Am Coll Cardiol 50 (2007) 2173-2195
10. Grambsch P.M., and Therneau T.M. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 81 (1994) 515-526
11. Schoenfeld D. Partial residuals for the proportional hazards regression model. Biometrika 69 (1982) 239-241
12. Rerkpattanapipat P., Morgan T.M., Neagle C.M., Link K.M., Hamilton C.A., and Hundley W.G. Assessment of preoperative cardiac risk with magnetic resonance imaging. Am J Cardiol 90 (2002) 416-419
13. McNeill A.J., Fioretti P.M., el-Said S.M., Salustri A., Forster T., and Roelandt J.R. Enhanced sensitivity for detection of coronary artery disease by addition of atropine to dobutamine stress echocardiography. Am J Cardiol 70 (1992) 41-46
14. Mieres J.H., Shaw L.J., Arai A., et al. Role of noninvasive testing in the clinical evaluation of women with suspected coronary artery disease: consensus statement from the Cardiac Imaging Committee, Council on Clinical Cardiology, and the Cardiovascular Imaging and Intervention Committee, Council on Cardiovascular Radiology and Intervention, American Heart Association. Circulation 111 (2005) 682-696
15. Geleijnse M.L., Fioretti P.M., and Roelandt J.R. Methodology, feasibility, safety and diagnostic accuracy of dobutamine stress echocardiograph. J Am Coll Cardiol 30 (1997) 595-606
16. Wallis J.W., Miller T.R., and Koppel P. Attenuation correction in cardiac SPECT without a transmission measurement. J Nucl Med 36 (1995) 506-512
17. Nagel E., Lehmkuhl H.B., Bocksch W., et al. Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI-comparison with dobutamine stress echocardiography. Circulation 99 (1999) 763-770
18. Wahl A., Paetsch I., Roethemeyer S., Klein C., Fleck E., and Nagel E. High-dose dobutamine-atropine stress cardiovascular MR imaging after coronary revascularization in patients with wall motion abnormalities at rest. Radiology 233 (2004) 210-216
19. Makaryus A.N., Shaw L.J., and Mieres J.H. Diagnostic strategies for heart disease in women: An update on imaging techniques for optimal management. Cardiol Rev 15 (2007) 279-287
20. Shaw L.J., Vasey C., Sawada S., Rimmerman C., and Marwick T.H. Impact of gender on risk stratification by exercise and dobutamine stress echocardiography: long-term mortality in 4234 women and 6898 men. Eur Heart J 26 (2005) 447-456
21. Hundley W.G., Rerkpattanapipat P., Little W.C., Link K.M., and Morgan T.M. Relation of cardiac prognosis to segment location with apical left ventricular ischemia. Am J Cardiol 92 (2003) 1206-1208
22. Elhendy A., Mahoney D.W., Khandheria B.K., Paterick T.E., Burger K.N., and Pellikka P.A. Prognostic significance of the location of wall motion abnormalities during exercise echocardiography. J Am Coll Cardiol 40 (2002) 1623-1629
23. Hyde R. Europe battles with obesity. Lancet 371 (2008) 2160-2161
24. Hogg K., Swedberg K., and McMurray J. Heart failure with preserved left ventricular systolic function. J Am Coll Cardiol 43 (2004) 317-327
25. Masoudi F.A., Havranek E.P., Smith G., et al. Gender, age, and heart failure with preserved left ventricular systolic function. J Am Coll Cardiol 41 (2003) 217-223
26. Dall'Armellina E., Morgan T.M., Mandapaka S., et al. Prediction of cardiac events in patients with reduced left ventricular ejection fraction with dobutamine cardiovascular magnetic resonance assessment of wall motion score index. J Am Coll Cardiol 52 (2008) 279-286
27. Gebker R., Jahnke C., Manka R., et al. Additional value of Myocardial perfusion imaging during dobutamine stress magnetic resonance for the assessment of coronary artery disease. Circ Cardiovasc Imaging 1 (2008) 122-130
28. Vakili B.A., Okin P.M., and Devereux R.B. Prognostic implications of left ventricular hypertrophy. Am Heart J 141 (2001) 334-341
29. Levy D., Garrison R.J., Savage D.D., Anderson Kannel W.B., and Castelli W.P. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart study. N Engl J Med 322 (1990) 1561-1566